UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047150
Receipt number R000053786
Scientific Title A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study
Date of disclosure of the study information 2022/03/11
Last modified on 2023/09/11 12:34:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study

Acronym

A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study

Scientific Title

A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study

Scientific Title:Acronym

A Randomized Controlled Trial to Evaluate the Efficacy of plant-protein diets in Patients with Chronic Kidney Disease: a pilot-study

Region

Japan


Condition

Condition

chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the efficacy of plant-protein diets for 4 weeks in patients with advanced chronic kidney disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in serum levels of indoxyl sulfate, p-Cresyl sulfate and trimethylamine N-Oxide

Key secondary outcomes

1) Change in eGFR and urinary protein creatinine ratio
2) Change in serum bicarbonate levels
3) Change in systolic and diastolic blood pressure
4) Change in serum levels of calcium, phosphate, intact parathyroid hormone and intact fibroblast growth factor 23
5) Change in serum levels of acetic acid, propionic acid and butyric acid
6) Change in gut microbiome composition
7) Change in muscle strength
8) Dietary adherence
9) Oral medications including antihypertensive drugs, diuretics, potassium tablets, potassium binders, phosphate binders, calcium tablets, active vitamin D3 analogs and sodium bicarbonate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

plant-protein diets

Interventions/Control_2

control diets

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with chronic kidney disease who were referred to the Outpatient Department of Nephrology at Osaka University Hospital
2) eGFR < 20 mL/min/1.73 m2
3) Taking anigiotensin-converting enzyme inhibitors or angiotensin II receptor blockers or angiotensin receptor neprilysin inhibitor
4) K < 5.5 mEq/L

Key exclusion criteria

1) Being planned to intitate renal replacement therapies within 3 months
2) Having inflammatory bowel diseases
3) History of gastrointestinal tract surgery
4) Taking antibiotics within 1 month before the entry
5) Taking or being planned to start warfarin
6) Having dietary allergies
7) Having difficulty in oral intake
8) During pregnancy or breastfeeding
9) Unsuitable for participant in the trial by an attending physician

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Sakaguchi

Organization

Osaka University Graduate School of Medicine

Division name

Department of Inter-Organ Communication Research in Kidney Diseases

Zip code

565-0871

Address

2-2, Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3747

Email

sakaguchi@kid.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Sakaguchi

Organization

Osaka University Graduate School of Medicine

Division name

Department of Inter-Organ Communication Research in Kidney Diseases

Zip code

565-0871

Address

2-2, Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3747

Homepage URL


Email

sakaguchi@kid.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

2-2, Yamadaoka, Suita, Osaka, Japan

Tel

06-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 11 Month 30 Day

Date of IRB

2022 Year 03 Month 28 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 11 Day

Last modified on

2023 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053786